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Background. The cellular chaperone protein Hsc70, along with components of the 26S proteasome and ubiquitin-conjugated
proteins have been shown to be sequestered in discrete foci in the nuclei of herpes simplex virus 1 (HSV-1) infected cells. We
recently reported that cellular RNA polymerase II (RNAP II) undergoes proteasomal degradation during robust HSV-1
transcription, and that the immediate early protein ICP27 interacts with the C-terminal domain and is involved in the
recruitment of RNAP II to viral transcription/replication compartments. Methodology/Principle Findings. Here we show that
ICP27 also interacts with Hsc70, and is required for the formation of Hsc70 nuclear foci. During infection with ICP27 mutants
that are unable to recruit RNAP II to viral replication sites, viral transcript levels were greatly reduced, viral replication
compartments were poorly formed and Hsc70 focus formation was curtailed. Further, a dominant negative Hsc70 mutant that
cannot hydrolyze ATP, interfered with RNAP II degradation during HSV-1 infection, and an increase in ubiquitinated forms of
RNAP II was observed. There was also a decrease in virus yields, indicating that proteasomal degradation of stalled RNAP II
complexes during robust HSV-1 transcription and replication benefits viral gene expression. Conclusions/Significance. We
propose that one function of the Hsc70 nuclear foci may be to serve to facilitate the process of clearing stalled RNAP II
complexes from viral genomes during times of highly active transcription.
Citation: Li L, Johnson LA, Dai-Ju JQ, Sandri-Goldin RM (2008) Hsc70 Focus Formation at the Periphery of HSV-1 Transcription Sites Requires
ICP27. PLoS ONE 3(1): e1491. doi:10.1371/journal.pone.0001491
INTRODUCTION
ThechaperoneproteinHsc70ispartofalarge groupofproteinsthat
assist in the folding and unfolding of proteins and in the assembly
and disassembly of macromolecular structures [1–4]. In addition to
protein folding, it has also been demonstrated that Hsc70 and an
interacting co-chaperone U-box protein termed CHIP (C-terminus
ofHsc70-interactingprotein),target aberrant forms of CFTR (Cystic
Fibrosis Transmembrane Conductance Regulator) protein for
proteasomal degradation by promoting their ubiquitination [5].
Burch and Weller [6] reported that in herpes simplex virus 1 (HSV-
1) infected cells, Hsc70 was sequestered in nuclear foci that also
contained components of the 26S proteasome and ubiquitin-
conjugated proteins. In subsequent studies, these authors also found
that Hsp90 and Hsp40 were redistributed to these sites, which they
termed VICE-domains, for virus-induced-chaperone-enriched [7].
The formation of these domains or foci at the periphery of viral
replication compartments suggests that they may function to rid
virus-infected nuclei of misfolded and ubiquitinated proteins via the
proteasome, perhaps to prevent premature apoptosis, which would
adversely affect viral replication.
We recently reported that during HSV-1 infection when viral
transcription is robust, cellular RNA polymerase II (RNAP II), and
specifically the serine-2 phosphorylated form of the C-terminal
domain (CTD) found in elongating transcription complexes [8–10],
undergoes ubiquitination and proteasomal degradation [11]. We
speculated that this may occur because HSV-1 encodes transcripts
frombothgenomicstrands,anditencodesmultiplesetsoftranscripts
that initiate at the same promoter but have different polyadenylation
sites or which initiate at different promoters but share a single
polyadenylation site. At times of active transcription of all kinetic
classes after DNA replication ensues, it is quite possible that
elongating RNAP II complexes may collide if both strands are being
transcribed at the same time, or may pile up on each other if 39
processing lags behind elongation. It has been shown in yeast and
mammalian cells that stalled RNAP II complexes become
ubiquitinatedanddegradedbytheproteasometoallow39processing
factorstoaccesstheRNAortoallowtrailingtranscriptioncomplexes
to proceed [12–15]. We and others have shown that expression of
the multifunctional regulatory protein ICP27 is essential for
abundant transcription of HSV-1 early and late genes [16–23],
and this is because ICP27 is required to recruit RNAP II to viral
replication sites [11]. ICP27 interacts with RNAP II [24], and
specifically with the CTD [11] and mutants of ICP27 that were not
able to interact with RNAP II also were not able to recruit RNAP II
to viral replication sites. In addition, viral replication compartment
formation was greatly impaired, viral transcription was severely
reduced, and proteasomal degradation of RNAP II was significantly
diminished in infections with these ICP27 mutants [11].
Based upon the reported composition of the Hsc70 nuclear foci or
VICE domains, we asked whether the formation of these discrete
nuclear structures at the periphery of viral replication compartments
was related to active viral transcription and RNAP II degradation.
Here, we show ICP27 also interacts with Hsc70 and that Hsc70
nuclear focus formation required ICP27 expression. During
infection with ICP27 mutants that cannot interact with RNAP II,
viral transcription-replication compartments were poorly formed
and Hsc70 focus formation was substantially delayed. Expression of
a dominant negative Hsc70 mutant reduced RNAP II degradation,
and this had adverse effects on viral replication. The results
presented here lead us to postulate that Hsc70 foci serve an
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PLoS ONE | www.plosone.org 1 January 2008 | Issue 1 | e1491important role during viral infection, which includes, but is likely not
limited to, aiding in the ubiquitination and proteasomal degradation
of stalled RNAP II complexes on viral genomes.
RESULTS
ICP27 Is Required for the Formation of Hsc70
Nuclear Foci
To determine if ICP27 played any role in the formation of Hsc70
nuclear foci, as has been shown for the HSV-1 immediate early
protein ICP0 [6], we analyzed the distribution of Hsc70 in wild type
HSV-1-infected cells compared to cells infected with 27-LacZ, an
ICP27 null mutant virus. In wild type HSV-1 infected cells at 6 h
after infection, staining of Hsc70 was seen to concentrate in distinct
nuclear foci, which occurred at the periphery of viral transcription-
replication compartments. These compartments were marked by
staining with antibody to the HSV-1 transcriptional activator ICP4
(Figure 1). In contrast, there was a diffuse nuclear and cytoplasmic
distribution of Hsc70 staining in 27-LacZ-infected cells, which was
similar to what was seen in mock-infected cells (Figure 1). Further,
viral transcription-replication compartments were poorly formed.
However, 27-Lac-Z infection of the complementing cell line, 2-2,
which expresses ICP27 in trans upon infection [25], resulted in the
formation of Hsc70 nuclear foci. Similarly, in Vero cells that were
transfected with a plasmid expressing ICP27, and which were then
infected with 27-LacZ, the formation of Hsc70 nuclear foci was seen
at the periphery of viral transcription-replication compartments
(Figure 1). Further, Hsc70 focus formation was seen in a cell
expressing ICP27, but not in the cell next to it, whichdid not express
ICP27 (Figure 1, bottom left panels). It should also be noted that
ICP27 expression was seen to be at similar levels in the 27-LacZ-
infected 2-2 cells and in the transfected Vero cells compared to WT
infection (Figure 1). We conclude that ICP27 expression is necessary
for the formation of Hsc70 nuclear foci during HSV-1 infection.
Figure 1. ICP27 Is Required for the Formation of Hsc70 Nuclear Foci. Vero cells or 2-2 cells were either mock-infected, infected with WT HSV-1 KOS
or ICP27 null mutant 27-LacZ, or were first transfected with plasmid pSG130B/S, which expresses ICP27 [48], and were then infected 24 h later with
27-LacZ, as indicated. All infections were performed at a moi of 10. Cells were fixed at 6 h after infection and stained with anti-Hsc70, anti-SC35, anti-
ICP4 and anti-ICP27 antibodies as indicated. Antibody to the nuclear splicing SR protein SC35 was used in the mock-infected sample to define the
nucleus. Arrows mark sites of Hsc70 nuclear foci (green) or ICP4-containing pre-replication sites (red). In this figure, and in all subsequent
immunofluorescence images, representative cells are shown at higher magnification to better illustrate the pattern of protein localization and to
observe intracellular structures. In all cases, cells shown in the figures represent the pattern observed in greater than 75% of the cells visualized in at
least 10 fields.
doi:10.1371/journal.pone.0001491.g001
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Interact with Hsc70 In Vitro and In Vivo
ICP27 is a highly interactive protein that has been shown to
interact with itself to form multimers [26] and with a number of
cellular proteins, including RNAP II [11,24], splicing factors
[27,28], and mRNA export factors Aly/REF and TAP/NXF1
[29–31]. To determine if ICP27 interacts with Hsc70, in vitro
binding assays were performed using bacterially-expressed GST-
Hsc70 protein encoding amino acids 1 to 540. This includes the
Nuclear Binding Domain (NBD- ATPase) and the Substrate
Binding Domain (SBD) but not the C-terminal Domain (CTD). In
vitro translated,
35S-methionine-labeled wild type and mutant
versions of ICP27 were used in these binding assays (Figure 2). WT
ICP27 and deletion mutants DDS5, S5, D26-101 and H17 were
seen to bind to GST-Hsc70; however, DN, in which amino acids 3
to 28 are deleted, and DC, in which residues 450 to 512 are
deleted, failed to bind to Hsc70 (Figure 2A). These results indicate
ICP27 binds Hsc70 in vitro and that both the N- and C-termini of
ICP27 must be intact for interaction. A similar result was found for
the interaction of ICP27 with RNAP II CTD and with TAP/
NXF1 [11,30], that is, both the N- and C-termini were
required for interaction. In assays with Hsc70 truncation mutants,
only the 1-540 species of Hsc70 bound to ICP27 (Figure 2B),
indicating that the ATPase domain and the substrate binding
domain of Hsc70 are required for interaction with ICP27 but not
the CTD.
To confirm the interaction of ICP27 with Hsc70 in virus-
infected cells, co-immunoprecipitation experiments were per-
formed. Cells were infected with WT HSV-1 strain KOS or with
ICP27 mutant viruses as indicated (Figure 3) and at 6 hours after
infection, cell lysates were immunoprecipitated with anti-ICP27
monoclonal antibody. Western blot analysis was performed with
anti-Hsc70 antibody. Hsc70 was co-immunoprecipitated with
ICP27 in WT HSV-1-infected cells and in cells infected with
mutants d1-2, d5-6 and n504 (Figure 3A). Hsc70 was not detected
in immunoprecipitated samples from cells infected with the null
mutant 27-LacZ, the N-terminal mutant dLeu, nor the C-terminal
mutant n406. Similarly, in the reverse immunoprecipitation
experiment performed with anti-Hsc70 antibody, ICP27 was not
detected in Hsc70 immunoprecipitated samples from 27-LacZ-,
dLeu- and n406-infected cells (Figure 3B). We conclude that
ICP27 interacts with Hsc70 in virus-infected cells and N-terminal
residues 6-19 and C-terminal residues 406 to 504 must be intact
for this interaction to occur.
Hsc70 Nuclear Sequestration Is Delayed in Infections
with N- and C-terminal ICP27 Mutants
To determine if Hsc70 was relocalized to nuclear foci during
infection with ICP27 mutants that do not interact with Hsc70,
immunofluorescent staining was performed. In cells infected with
WT HSV-1, Hsc70 focus formation was clearly seen by 6 h after
infection, a time when ICP27 is still strongly nuclear, but it has
Figure 2. ICP27 Associates with Hsc70 in vitro. A) GST-binding assays were performed with GST-Hsc70 (1-540) and in vitro translated WT ICP27 and
mutants DN, D2DS5, S5, D26-100, H17 and DC. Asterisks mark the position of the ICP27 proteins that were seen to bind. Input
35S-labeled proteins are
shown in the middle panel. In the bottom panel, a schematic diagram of the 512 amino acid ICP27 coding region, including the leucine-rich amino
terminus (LRR), nuclear localization signal (NLS), RGG box RNA binding motif (RGG), arginine-rich region (R2), three predicted KH domains and a zinc-
finger-like motif (CCHC) in the C-terminus. The positions of the deletion mutations (dotted lines) are shown below. B) GST binding assays were
performed with
35S-labeled, in vitro-translated WT ICP27 and GST-tagged Hsc70 truncated proteins. The arrow shows the position of ICP27. Input
GST-Hsc70 proteins are shown in the middle panel. A schematic of the Hsc70 coding region is shown illustrating the nucleotide binding domain
(NBD-ATPase), the substrate binding domain (SBD) and the C-terminal domain (CTD).
doi:10.1371/journal.pone.0001491.g002
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factor (Figure 4A). The shuttling of ICP27 can be seen more
clearly at 8 h after infection (Figure 4A). In contrast, in dLeu-
infected cells, Hsc70 foci were not observed even by 8 h after
infection; while in n406-infected cells, small Hsc70 foci were seen
but not until 8 h after infection, when larger foci are apparent in
WT-infected cells (Figure 4A). Because viral replication is both
curtailed and delayed in n406 infected cells, the smaller foci seen
at 8 h in n406 infections, probably reflect the timing of the
beginning of DNA replication. Further, both dLeu and n406 are
confined to the nucleus because these ICP27 mutants do not
interact with TAP/NXF, which is required for ICP27 to shuttle to
the cytoplasm [29]. Interestingly, mutant n504, which also does
not interact with TAP/NXF1 was confined to the nucleus at 6 h
after infection, however, Hsc70 foci were seen to form. This
mutant does interact with Hsc70.
Burch and Weller [6] reported that the HSV-1 immediate early
protein, ICP0, which encodes an E3-ubiquitin ligase in its RING
domain [32], was necessary to establish Hsc70 foci at early times
during infection and was sufficient to redistribute chaperone
molecules in transfected cells. Immunofluorescent staining of ICP0
and Hsc70 in WT and ICP27 mutant infected cells showed that
ICP0 was similarly expressed in a nuclear punctate staining pattern
at6 hafterinfection;however,Hsc70fociwereonlyobservedinWT
HSV-1-infected cells (Figure 4B). These results corroborate the
results shown in Figure 1 indicating that ICP27 is also required for
the nuclear sequestration of Hsc70 in HSV-1-infected cells.
Hsc70 Focus Formation Correlates with HSV-1
Transcription-Replication Compartment Formation
Viral transcription and replication is greatly reduced during
infection when ICP27 is not expressed, as in 27-LacZ infection,
and in infections with ICP27 mutants that cannot interact with
RNAP II to recruit it to viral replication sites [11,18,23,33,34].
Mutants dLeu and n406 do not interact with RNAP II [11]. As a
Figure 3. The N- and C-termini of ICP27 Are Required for Interaction with Hsc70 during Infection. A) HeLa cells were either mock-infected or
infected with WT HSV-1 or ICP27 mutants as indicated. At 6 h after infection, nuclear extracts were prepared. Expression of endogenous Hsc70 in
mock-infected cells and HSV-1 WT- and mutant-infected cells is shown by Western blot analysis of samples from nuclear extracts in the top panel.
Immunoprecipitations with anti-ICP27 antibody followed by Western blot analysis with anti-Hsc70 antibody are shown in the middle panel. The
bottom panel shows a Western blot of anti-ICP27 immunoprecipitated samples probed with anti-ICP27 antibody to show ICP27 expression. Asterisks
(*) mark WT and mutant ICP27 protein bands. The + signs mark heavy chain IgG from the immunoprecipitations. B) Reverse immunoprecipitations
were performed on samples from the nuclear extracts described above. The top panel shows the expression of WT and mutant ICP27 in the nuclear
extracts. Immunoprecipitation of each sample was performed with anti-Hsc70 antibody and Western blot analysis was performed by probing with
anti-ICP27 antibody, as shown in the middle panel. The + sign marks heavy chain IgG from the immunoprecipitation. The bottom panel shows a
Western blot of anti-Hsc70 immunoprecipitated samples probed with anti-Hsc70 antibody. C) A schematic diagram of the ICP27 coding region is
shown in the left panel with the positions of the deletions illustrated by dotted lines. The table in the right panel describes the residues deleted or
mutated in each mutant virus.
doi:10.1371/journal.pone.0001491.g003
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marked by staining for ICP4, and replication compartments were
poorly formed (Figure 5A, compare WT to dLeu and n406). The
inefficient recruitment of RNAP II to viral replication sites is the
likely cause of the low levels of early and late viral transcripts
produced during infection with these mutants compared to WT, as
shown by microarray analysis (Figure 5B) using an array of HSV-1
DNA probes that span the genome, as described previously [35].
The low levels of viral transcripts in turn results in very low levels
of DNA replication for these mutants as shown by quantitative
PCR with a probe for the viral glycoprotein C (gC) gene, which
resides in the unique long region of the viral genome. While viral
DNA copies per cell were amplified about 9000 fold in WT HSV-
1 infected cells by 12 h after infection, little increase in DNA copy
number was seen in mutant infected cells (Figure 5C).
Next, we analyzed Hsc70 nuclear focus formation and viral
replication compartment formation in ICP27 mutant virus-
infected cells compared to WT at different times after infection.
While Hsc70 foci were seen to form adjacent to pre-replication
compartment structures by 4 h after infection in WT-infected cells
(Figure 6), there was little evidence of Hsc70 foci even by 8 h in
27-Lac Z and dLeu-infected cells, and viral replication compart-
ment formation was also greatly compromised. Small foci of
Hsc70 were seen in n406-infected cells but not until 8 h after
infection, when ICP4 containing pre-replication sites could be seen
(Figure 6). Thus, it appears that Hsc70 nuclear sequestration and
focus formation correlates with the formation of HSV-1
replication compartments and Hsc70 nuclear foci are most
apparent with fully formed viral replication compartments.
Hsc70 Foci Arise Concomitantly with the Loss of
Serine-2 phosphorylated RNA Polymerase II
A unique feature of HSV-1 transcription is that there is decrease in
the serine-2 phosphorylated form of the RNAP II CTD, which is
found in RNAP II elongating complexes [11,36,37]. This is
accompanied by an overall decrease in RNAP II protein levels at
later times during infection when viral transcription is very robust.
This decrease results from proteasomal degradation of RNAP II
because it can be prevented by adding the proteasome inhibitors
MG132 or lactacystin [11]. During infections with ICP27 mutants
that fail to interact with RNAP II, viral transcription is greatly
reduced and delayed and so is the degradation of RNAP II [11].
Thus, we concluded previously that phospho-serine-2 RNAP II
degradation most likely occurred during highly active viral
transcription and that it resulted from elongating complexes stalling
in high traffic areas of the genome [11]. Proteasomal degradation
would clear the stalled complexes. Therefore, we next sought to
determine if Hsc70 focus formation was tied to efficient recruitment
of RNAP II to viral replication sites, resulting inrobusttranscription,
which could then lead to RNAP II degradation. Hsc70 nuclear
structures have been reported to contain components of the
proteasomal machinery [6], and therefore the localization of these
foci at the periphery of viral transcription-replication sites may serve
an important function in facilitating ubiquitination and proteasomal
degradation of stalled RNAP II complexes.
To monitor relocalization of RNAP II to viral replication
compartments, staining was performed with monoclonal antibody
H14, which recognizes the serine-5 phosphorylated form of RNAP
Figure 4. Hsc70 Nuclear Focus Formation Is Delayed in Infections with ICP27 Mutants. A) Vero cells were infected with WT HSV-1 or mutants dLeu,
n406 or n504. At the times indicated, cells were fixed and stained with anti-Hsc70 and anti-ICP27 antibodies as indicated. Arrows mark Hsc70 nuclear
foci. B) Vero cells were infected with WT HSV-1, 27-LacZ, dLeu, n406 or n504 for 6 h, at which time cells were fixed and stained with anti-Hsc70 and
anti-ICP0 antibodies. The arrow marks an Hsc70 focus adjacent to an ICP0 speckle.
doi:10.1371/journal.pone.0001491.g004
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phosphorylated RNAP II was recruited to structures resembling
viral replication compartments by 8 h after infection in WT HSV-1-
infected cells, and Hsc70 foci formed at the periphery of these
structures (Figure 7, left panels). To show that these structures were
indeedreplication compartments,H14stainedcellswerealsostained
with antibody to ICP4 (Figure S1). It is clear that serine-5 RNAP II
stained by H14 antibody colocalized with ICP4-marked replication
compartments. In contrast, in dLeu and n406 infections, H14
staining wassimilartomockinfected cellsat 8 h fordLeu and6 h for
n406-infected cells (Figure 7, left panels). It was not until later times
with these mutants that small Hsc70 foci were seen to form along
with small compartments that stained with H14, and which
presumably represent viral pre-replication sites (Figure 7, left panels
and Figure S1).
Degradation of the serine-2 phospho-form of RNAP II CTD was
assessed by staining with monoclonal antibody H5 (Figure 7, right
panels), which recognizes the serine-2 phosphorylated CTD [38,39].
We showed previously that along with proteasomal degradation of
RNAP II during HSV-1 infection, there is a loss of H5 staining and
the subset of H5 stained structures that remain have a speckled
appearance [11], because this antibody cross-reacts with a phospho-
epitope of SR protein splicing factors [40]. Fraser and Rice [36]
reported a similar finding in HSV-1 infected cells. The cross-
reactivity of H5 with SR proteins occurs when levels of serine-2
phosphorylatedRNAPIICTDarelowandSRproteinsarefarmore
abundant [40].Thus,RNAP IIdegradationcan be monitored bythe
change in the staining pattern seen with H5 antibody [11,36,37]. In
mock infected cells, H5 staining is diffuse throughout the nucleus,
and this is also seen at 4 h in WT HSV-1 infected cells (Figure 7,
right panels). However, by 8 h, H5 staining was greatly reduced and
the staining was now confined to speckled structures (Figure 7 and
Figure S1). That these speckled structures were splicing factors was
confirmed by staining with a monoclonal antibody to SR protein
SC35 (Figure S2). Further, Hsc70 focus formation correlated with
the appearance of H5 speckles, and the Hsc70 foci were adjacent to
the speckles (Figure 7, right panels, and Figure S2, lower panel).
In dLeu and n406 infections, the appearance of Hsc70 nuclear
foci, and H5 speckled staining was greatly delayed and was not
apparent until 12 h after infection (Figure 7, right panels, and Figure
S2, middle panels). This is in accord with the reduced and delayed
viral transcription pattern seen in infections with these mutants
Figure 5. ICP27 N- and C-Terminal Mutants Show Poor Replication Compartment Formation and Reduced Transcription and DNA Replication. A)
Vero cells were infected with WT HSV-1, dLeu or n406 for 8 h, at which time cells were fixed and stained with anti-RNAP II antibody ARNA3, which
recognizes all forms of RNAP II, and anti-ICP4 antibody. The arrows point to a fully formed replication compartment in WT-infected cells and to small
pre-replication sites in dLeu and n406-infected cells. B) HeLa cells were infected with WT HSV-1, dLeu or n406 as indicated. At 8 h after infection total
RNA was extracted and microarray analysis was performed as described previously against an array of HSV-1 transcript-specific probes [35].
Hybridizations were performed in triplicate and the experiments were performed twice. Error bars represent the standard deviations. C) Vero cells
were mock-infected or were infected with WT HSV-1, 27-LacZ, dLeu or n406 at a moi of 10. At 1 h and 12 h after infection, DNA was purified from cell
lysates by phenol-chloroform extraction. Quantitative real-time PCR was performed with a probe for the glycoprotein C (gC) gene to determine viral
DNA copy number.
doi:10.1371/journal.pone.0001491.g005
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Therefore, the appearance of Hsc70 nuclear foci at the periphery of
viral transcription/replication sites may occur as a result of the
ubiquitination of RNAP II on stalled elongating complexes in high
traffic areas of an actively replicating viral genome.
Preventing RNAP II Degradation Also Prevents
Hsc70 Focus Formation
The degradation of RNAP II during HSV-1 infection can be
prevented by addition of the proteasomal inhibitor MG132 [11].
We asked what effect MG132 would have on Hsc70 focus
formation. There was no change in the diffuse nuclear and
cytoplasmic staining of Hsc70 in mock and 27-LacZ-infected cells
with or without MG132 (Figure 8). In contrast, Hsc70 nuclear
focus formation was curtailed in WT HSV-1-infected cells in the
presence of MG132, as was the appearance of H5 speckled
structures (Figure 8). Therefore, preventing the proteasomal
degradation of RNAP II during HSV-1 infection also precludes
the formation of Hsc70 nuclear foci.
An Hsc70 Dominant Negative Mutant Can Prevent
RNAP II Degradation and Focus Formation
A loss of function mutant of Hsc70, which has a methionine
substituted for lysine 71 in the ATPase domain, has been shown to
be unable to hydrolyze ATP, which is essential for Hsc70 function
[41]. Mutant Hsc70 K71M behaves in a dominant negative fashion
whenexpressed inculturedcells,inthatitinterfereswithendogenous
Hsc70 function [1,41,42]. To determine first if Hsc70 K71M was
capable of interacting with ICP27, cells were transfected with GFP-
tagged Hsc70 K71M and with GFP-tagged Hsc70 as a control. Cells
were infected with WT HSV-1 and co-immunoprecipitations were
performed on cell lysates. In samples that were immunoprecipitated
with antibody against ICP27, GFP-Hsc70 was co-immunoprecipi-
tated, as shown by probing a Western blot with antibody to GFP
(Figure S3, middle panel). GFP-Hsc70 K71M was not found to be
precipitated with ICP27. In re-probing the same blot with antibody
against Hsc70, it was seen that endogenous Hsc70 was also present
inthe immunoprecipitated ICP27 complexes incontrol transfections
with GFP and in transfections with GFP-Hsc70 (Figure S3, right
panel). However, endogenous Hsc70 was not seen in samples from
cells expressing GFP-Hsc70 K71M, the dominant negative mutant.
This indicates that not only does Hsc70 K71M fail to interact with
ICP27, but also that it appears to interfere with the interaction of
endogenous Hsc70 and ICP27.
To determine if Hsc70 K71M would interfere with Hsc70 focus
formation during HSV-1 infection, cells transfected with GFP-
Hsc70 K71M or GFP-Hsc70 were subsequently infected with WT
HSV-1 for 8 h. Hsc70 localization was monitored by immunoflu-
orescent microscopy. In cells transfected with GFP-Hsc70, nuclear
Figure 6. Hsc70 Focus Formation Correlates with HSV-1 Replication Compartment Formation. Vero cells were infected with WT HSV-1, 27-LacZ,
dLeu or n406. At the times indicated, cells were fixed and stained with anti-Hsc70 and anti-ICP4 antibodies. Arrows point to Hsc70 foci (green) or pre-
replication sites (red).
doi:10.1371/journal.pone.0001491.g006
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replication compartment formation marked by staining for ICP4
and ICP8, a viral DNA replication protein (Figure 9A). In
contrast, in cells expressing GFP-Hsc70 K71M, there was a diffuse
nuclear and cytoplasmic distribution with no focus formation.
Even more interesting was the staining of H5 in the cell expressing
GFP-Hsc70 K71M, which remained diffuse in the nucleus rather
than localizing to speckles as in the infected cells not expressing
GFP-Hsc70 K71M (Figure 9B). This suggests that degradation of
RNAP II was not occurring in the presence of the dominant
negative mutant. Further, viral replication compartment forma-
tion was also hampered by the dominant negative Hsc70 mutant,
as seen in the cells stained with ICP4 and ICP8 antibodies, and
which also expressed GFP-Hsc70 K71M (Figure 9B).
To further explore the apparent inhibition of RNAP II
degradation by the Hsc70 dominant negative mutant, Western
blot analysis was performed on nuclear extracts from cells that
were transfected with GFP or GFP-Hsc70 as controls, or with
GFP-Hsc70 K71M. Cells were subsequently mock-infected or
were infected with WT HSV-1 or 27-LacZ. Blots were probed
with antibody H5 to detect the serine-2 form of RNAP II CTD.
Note that in Western blots, cross-reactivity of H5 with SR proteins
does not prevent detection of serine-2 RNAP II CTD because its
apparent molecular weight is greater than 180 kDa, whereas, the
cross-reacting SR proteins are around 35 kDa. Levels of serine-2
phosphorylated RNAP II CTD were similar in all samples from
mock infected cells and in all samples from cells infected with 27-
LacZ (Figure 10A). This is in accord with our previous finding that
there is no discernible loss of the serine-2 form in mock infected
cells, and that degradation of RNAP II occurs to a lesser extent
and at much later times in 27-LacZ infected cells, which are
severely defective in viral transcription [11,43]. On the other
hand, there was a marked reduction in the serine-2 form of RNAP
II in WT HSV-1 infected cells, such that it was not detectable in
cells transfected with GFP alone and was barely detectable in cells
transfected with GFP-Hsc70, indicating that proteasomal degra-
dation had occurred. The dominant negative Hsc70 K71M
interfered with RNAP II degradation, because levels of the serine-
2 phospho-form that were detected were significantly higher
compared with the controls (Figure 10A). The rescue of RNAP II
from degradation by Hsc70 K71M was on par with the addition of
MG132 (Figure 10B). When MG132 was added to WT HSV-1
infected cells at different times after infection, there was inhibition
of phosphoserine-2 RNAP II and total RNAP II degradation, with
the greatest effects seen with the early addition of the drug before
robust viral transcription and replication (Figure 10B).
Figure 7. Hsc70 Nuclear Sequestration Correlates with the Loss of Phospho-serine 2 Form of RNAP II CTD in Fully Formed Replication
Compartments. Vero cells were mock-infected or infected with WT HSV-1, dLeu or n406 for the times indicated. In the left hand panels, cells were
stained with anti-RNAP II antibody, H14, which recognizes phospho-serine 5 RNAP II CTD, and anti-Hsc70 antibody. Arrows show a replication
compartment with an Hsc70 focus site at the periphery in the 8 h WT-infected cell, and a pre-replication site (red) next to a small Hsc70 focus site
(merge) in the 12 h dLeu-infected cell. In the right panels, cells were stained with anti-Hsc70 antibody and anti-RNAP II antibody H5, which recognizes
phospho-serine-2 RNAP II CTD. This antibody also cross-reacts with a phospho-epitope in splicing SR proteins [11,40]. The arrow points to an Hsc70
focus site (green) adjacent to a splicing speckle (red).
doi:10.1371/journal.pone.0001491.g007
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during HSV-1 infection, and that higher levels of ubiquitinated
species were seen in the presence of MG132, because degradation
by the proteasome was precluded [11]. To determine if the
dominant negative Hsc70 mutant could similarly trigger an
increase in ubiquitinated RNAP II, immunoprecipitation with
anti-ubiquitin antibody was performed on nuclear extracts from
HSV-1 infected cells that had been transfected with GFP or GFP-
Hsc70 as controls or GFP-Hsc70 K71M. Western blots were then
probed with an antibody that recognizes all forms of RNAP II,
both phosphorylated and unphosphorylated. Higher migrating
bands were detected and the intensity of these bands was greater in
the sample from cells expressing the dominant negative Hsc70
mutant (Figure 10C). In addition, it can be seen from the nuclear
extract samples that total RNAP II levels were reduced in the
control GFP and GFP-Hsc70 samples, compared to the GFP-
Hsc70 K71M sample (Figure 10C, left panels). These results
indicate that the dominant negative Hsc70 mutant interferes with
the degradation of ubiquitinated RNAP II. We showed previously
[11] that prevention of RNAP II degradation by MG132 or
lactacystin results in a reduction in viral yields. We also saw a
decrease in virus yield in cells transfected with the Hsc70 K71M
mutant (Figure 10D). Although yields were reduced only about 20
fold, this may be an underestimate of the effect because only a
subset of the infected cells was successfully transfected with the
dominant negative mutant plasmid. Thus, we conclude that
clearing of stalled RNAP II complexes during robust transcription
and DNA replication is beneficial for HSV-1 infection, and
preventing proteasomal degradation is detrimental.
DISCUSSION
It has been reported that RNAP II elongating complexes that stall
on DNA templates due to DNA damage or to a build up of
elongating complexes in highly transcribed genes are subject to
ubiquitination and proteasomal degradation [13,15,44,45]. We
have reported that during HSV-1 infection, RNAP II becomes
ubiquitinated and undergoes proteasomal degradation that can be
prevented by the addition of MG132 and lactacystin [11]. The
phospho-serine 2 form of the CTD, found in the elongating
complex, is most severely affected. Further, prevention of RNAP II
degradation by proteasome inhibitors resulted in decreased levels
of viral late proteins and reduced viral yields [11]. The
degradation of RNAP II occurred earlier in infection and was
more profound in wild type HSV-1 infected cells compared to
infections with viral mutants that either did not express ICP27 or
in which the mutant ICP27 was unable to interact with and recruit
RNAP II to viral replication sites [11]. These mutants accumulate
low levels of viral transcripts and have greatly reduced DNA
replication ([11] and Figure 5). These results led us to postulate
that when HSV-1 genomes are undergoing robust transcription
and DNA replication, elongating RNAP II complexes may collide,
especially in regions of the genome where transcripts are being
transcribed on both strands; in regions where several transcripts
share the same polyadenylation sites, and in regions where the 39
end of a gene is juxtaposed or even overlaps the promoter region
of another gene. Resolution of these stalled complexes by
proteasomal degradation may be necessary to allow 39 processing
factors to access the transcript or to clear the road for transcription
complexes approaching the stalled complexes.
Figure 8. Preventing Phospho-serine 2 RNAP II Degradation Also Prevents Hsc70 Focus Formation. Vero cells that were mock-infected or were
infected with WT HSV-1 or 27-LacZ were untreated (left panels) or were treated with 50 mM MG132 added 1 h after infection (right panels). Cells were
fixed at 8 h after infection and stained with anti-Hsc70 antibody, antibody H5 and anti-ICP4 antibody as indicated. Arrows mark Hsc70 foci (green) or
replication or pre-replication sites (red).
doi:10.1371/journal.pone.0001491.g008
Hsc70 Nuclear Foci Need ICP27
PLoS ONE | www.plosone.org 9 January 2008 | Issue 1 | e1491ICP27 is a multifunctional protein that interacts with a
multitude of proteins, and which functions at both the transcrip-
tional and post-transcriptional level. Its stimulation of viral
transcription appears to stem from its recruitment of RNAP II
to viral replication sites. Thus, ICP27 acts indirectly in
transcription, that is, it recruits RNAP II. ICP27 was also found
to interact with Hsc70 (Figures 2 and 3), and to be required for its
redistribution to nuclear foci or VICE domains. We postulate that
these foci either serve as sites where misfolded or ubiquitinated
proteins are targeted and are consequently degraded, or more
likely, that these foci serve as reservoirs or storage sites for the
proteasomal degradation machinery, much like splicing speckles
are thought to serve as storage sites for mRNA processing factors.
The localization of the foci at the periphery of viral transcription-
replication compartments would provide an efficient access to
stalled transcription complexes, which would then be ubiquiti-
nated and degraded. Hsc70 may even promote ubiquitination of
RNAP II for degradation by the proteasome because the
dominant negative mutant partly blocked this occurrence.
A model to explain the role of ICP27 in this process is shown in
Figure 11. ICP27 interacts with the CTD of RNAP II early in
infection and recruits RNAP II to sites of viral DNA, which develop
into replication compartments [46,47]. The HSV-1 genome encodes
transcripts on both strands, as well overlapping transcripts that share
59 or 39 ends. Thus, during robust viral transcription, it is
conceivable that elongating RNAP II complexes may collide and
thus stall as depicted in Figure 11. Additionally, elongating RNAP II
complexes may pile up in regions where there are several transcripts
that share 39 ends, and which may be transcribed with different
kinetics. Clearance of these roadblocks is required to allow
transcription to continue and to allow 39 end formation. Compo-
nents of the nuclear foci or VICE domains, including Hsc70 may
then be called into action to ubiquitinate and degrade the stalled
complexes. Hsc70 appears to play an important role in HSV-1
replication because when its action was blocked by the dominant
negative mutant, viral yields were reduced, just as occurred with the
addition of proteasome inhibitors.
These studies have uncovered yet another layer to the
complexity of activities that are mediated by ICP27. In addition
to its reported transcriptional and post-transcription roles, we now
show that ICP27 is also involved in the resolution of stalled RNAP
II complexes by proteasomal degradation through its interaction
with and redistribution of Hsc70.
MATERIALS AND METHODS
Cells, viruses and recombinant plasmids
Vero cells, HeLa R19 cells and rabbit skin fibroblasts (RSF) were
grown on minimal essential medium containing 10% fetal bovine
serum. Vero 2-2 cells were grown in medium containing 750 mg/ml
G418 as described previously [25]. HSV-1 strain KOS and 27-LacZ
were described previously [25]. ICP27 viral mutants dLeu, d1-2, d5-
6, n406 and n504 were generously provided by Steve Rice, and have
been described previously [18,21,23]. ICP27 recombinant plasmids,
pDN, pD2DS5, pH17, pDCa n dp D26-100 were described [11].
Plasmids pGEX-Hsc70 (1-540), pGEX-Hsc70 (373-540), pGEX-
Hsc70 (373-650) and pGEX-Hsc70 (540-650) were generously
provided by Ernst Ungewickell [4]. Plasmids pcDNA3.1-Hygro(+)-
Myc-Hsc70 and pcDNA3.1-Hygro(+)Myc-Hsc70K71M expressing
Myc-Hsc70 and Myc-Hsc70K71M were generously provided by
Daniel Manor [3]. Plasmids pEGFPC3-Hsc70 and pEGFPC3-
Hsc70K71M were constructed by ligating Hsc70 and Hsc70K71M
cDNA in frame into pEGFC3 vector (Clonetech).
Figure 9. An Hsc70 Dominant Negative Mutant Can Prevent RNAP II Phospho-serine 2 Degradation and Hsc70 Focus Formation. A) Vero cells
were transfected with pGFP-Hsc70 and were subsequently infected with WT HSV-1 for 8 h. Cells were stained with H5, anti-ICP4 or anti-ICP8
antibodies. GFP fluorescence was viewed directly. Arrows point to Hsc70 foci. B) Vero cells were transfected with the dominant negative mutant GFP-
Hsc70K71M and then infected with WT HSV-1 for 8 h. Cells were stained with H5, anti-ICP4 or anti-ICP8 antibodies. Arrows point to GFP Hsc70K71M
expressing cells showing diffuse nuclear staining with H5, and to pre-replication sites in cells stained for ICP4 and ICP8. The yellow arrows in the ICP4
and ICP8 stained panels point to a fully formed replication compartment.
doi:10.1371/journal.pone.0001491.g009
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immunoprecipitation procedures
Transfection of plasmid DNA was performed using Lipofectamine
(Invitrogen) according to the manufacturer’s protocol. Twenty-four
hours after transfection, cells were infected with WT or mutant
HSV-1 as indicated at a multiplicity of infection (moi) of 10. For
direct infections without prior transfection, cells were infected with
WT or ICP27 mutant viruses at a moi of 10. Nuclear extracts and
whole cell extracts were prepared at the times indicated as described
previously [26,27,29,30]. Immunoprecipitations were performed as
described previously [11] with anti-ICP27 monoclonal antibody
H1113(Virusys),anti-Hsc70antibody(StressGen)andanti-ubiquitin
antibody (StressGen). Gel electrophoresis and immunoblotting
procedures were performed as described [11,29,30].
In vitro binding assays
GST-binding assays were performed at room temperature by
combining 10 ml of Glutathione-Sepharose-bound GST proteins
with 10 ml of in vitro translation reaction containing
35S-
methionine labeled WT ICP27 or mutant versions as described
[27,29]. Beads were washed four times and bound proteins were
fractionated by SDS-polyacrylamide gel electrophoresis.
Immunofluorescence microscopy
Cells were grown on coverslips and transfected and/or infected as
described in the figure legends. Infections with WT or ICP27
mutants were performed at a moi of 10. At the indicated times,
cells were fixed in 3.7% formaldehyde and immunofluorescent
staining was performed as described previously [11,27] with anti-
Figure 10. Dominant Negative Mutant Hsc70 K71M Prevents Proteasomal Degradation of Phospho-Serine 2 RNAP II CTD. A) RSF cells were
transfected with vector alone (-), Myc-tagged Hsc70 or Myc-tagged Hsc70K71M and 24 h later were either mock-infected or were infected with WT
HSV-1 or 27-LacZ. Nuclear extracts were prepared 8 h after infection. Western blots were probed with antibody H5 to detect the phospho-serine 2
form of RNAP II; anti-myc antibody to detect myc-tagged Hsc70; anti-ICP27 antibody to monitor ICP27 expression, and anti-YY1 antibody as a loading
control. YY1 is a cellular transcription factor. B) HeLa cells were either mock-infected or infected with WT HSV-1. MG132 (50 mM) was added at the
times indicated and nuclear extracts were prepared at 8 after infection. Western blots were probed with H5 antibody to detect RNAP II phospho-
serine 2; ARNA3 antibody, which recognizes all forms of RNAP II, both phosphorylated and unphosphorylated; anti-ICP27 antibody, and anti-YY1
antibody. C) RSF cells were transfected with empty vector alone (control), myc-tagged Hsc70 or myc-tagged Hsc70K71M as indicated, and were
infected 24 h later with WT HSV-1. Nuclear extracts were prepared 8 h after infection, and samples were fractionated directly by SDS-PAGE for
Western blot analysis (left panel, NE) or were immunoprecipitated with anti-ubiquitin antibody (right panel, IP- anti-Ub). Immunoprecipitated
complexes were fractionated by SDS-PAGE and the Western blot was probed with anti-RNAP II antibody ARNA3. Arrows point to slower migrating
ubiquitinated forms of RNAP II. D) RSF cells were transfected with empty vector alone (control), myc-tagged Hsc70 or myc-tagged Hsc70K71M and
were infected 24 h later with WT HSV-1. Cells were harvested 24 h after infection and viral titers were determined by plaque assays.
doi:10.1371/journal.pone.0001491.g010
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PLoS ONE | www.plosone.org 11 January 2008 | Issue 1 | e1491ICP27 monoclonal antibodies H1119 or H1113 (Virusys), anti-
ICP4 monoclonal antibody H1101 (Virusys), anti-ICP0 monoclo-
nal antibody H1112 (Virusys), anti-ICP8 antibody H1115
(Virusys), anti-RNAP II antibodies H5 and H14 (Covance
Research Products), anti-RNAP II antibody ARNA3 (Research
Diagnostics), anti-Hsc70 antibody (StressGen) and anti-SC35
hybridoma supernatant [27]. Procedures for the serial treatment
of cells with different monoclonal antibodies were described
previously [27]. GFP fluorescence was viewed directly. Cells were
viewed with a Zeiss Axiovert S100 microscope. Images were
pseudocolored and merged using Adobe Photoshop.
SUPPORTING INFORMATION
Figure S1 Phospho-serine 5 RNAP II Colocalizes with HSV-1
Replication Compartments. Vero cells were infected with WT
HSV-1, dLeu or n406 for the times indicated. Cells were stained
with H14 antibody, which recognizes RNAP II phosphoserine-5
and with ICP4 to mark replication compartments (left panels).
Cells were stained with H5 antibody, which recognizes the serine-
2 phospho-form of RNAP II CTD, and which cross-reacts with
SR protein SC35 under conditions in which serine-2 RNAP II
levels are low and SR protein levels are high [11,40]. Cells were
also stained ICP4 antibody (right panels). Arrows in the left panels
point to H14 (green) structures (green) that colocalize with ICP4-
marked replication compartments (red) for WT infected cells at
8 h or a pre-replication site for the n406 infected cell. The arrows
in the right panels show H5 staining in a speckled splicing
structure (green) and ICP4 marked replication compartment (red).
Found at: doi:10.1371/journal.pone.0001491.s001 (2.23 MB TIF)
Figure S2 Loss of Phospho-serine 2 Staining Does Not Occur in
ICP27 Mutant d-Leu and n406 Infections. Vero cells were
infected with WT HSV-1, dLeu or n406 for 8 h. Cells were
stained with H5 antibody, which recognizes the serine-2 phospho-
form of RNAP II CTD, and which cross-reacts with SR protein
SC35 under conditions in which serine-2 RNAP II levels are low
and SR protein levels are high [11,40]. Cells were also stained with
anti-SC35, and in the bottom panel, anti-Hsc70 antibody. Arrows
point to an H5-SC35 splicing speckle in the top panels, and to an
Hsc70 focus adjacent to an SC35 splicing speckle in the bottom
merge panel.
Found at: doi:10.1371/journal.pone.0001491.s002 (2.21 MB TIF)
Figure S3 Dominant Negative Mutant Hsc70K71M Does Not
Interact with ICP27. A) Schematic diagram of Hsc70 showing the
position of the lysine to methionine substitution in the ATPase
domain of Hsc70. B) RSF cells were transfected with a GFP
control plasmid or with GFP-Hsc70 or mutant GFP-Hsc70K71M.
Twenty-four hours later cells were infected with WT HSV-1 for
8 h. Immunoprecipitation was performed with anti-ICP27 anti-
body and protein complexes were fractionated by SDS-PAGE and
transferred to nitrocellulose. The Western blot was first probed
with anti-ICP27 antibody (left panel). The same blot was washed
and subsequently probed with anti-GFP antibody (middle panel).
The arrow indicates the position of GFP-Hsc70. The blot was
again washed and probed with anti-Hsc70 antibody (right panel).
The arrow indicates the position of endogenous Hsc70. The bands
marked with asterisks are heavy chain IgG from the immunopre-
cipitations.
Found at: doi:10.1371/journal.pone.0001491.s003 (0.67 MB TIF)
Figure 11. Model of RNAP II Degradation during HSV-1 Transcription. ICP27 interacts with the CTD of RNAP II [11] and recruits RNAP II to a viral
replication compartment [11,34], which is represented in magenta. Elongating RNAP II complexes on opposite DNA strands may collide causing one
or both complexes to stall. At least one of the stalled complexes may then be ubiquitinated and degraded by the proteasome. The other transcription
complex is now free to continue. Hsc70 foci, which form at the same time as replication compartments, and which lie at their periphery, may aid this
process by providing a ready source of chaperone proteins as well as other components of the 26S proteasome [6,7].
doi:10.1371/journal.pone.0001491.g011
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